Search Results 321-330 of 715 for ⚠위너 [원탑보증.com/가입코드 111] sbc가입코드 ⚠

1. Define in Humans With Compensated CHF and Renal Dysfunction, the Modulating Action of Chronic AT1 Receptor Blockade in Addition to ACE Inhibition on Cardiorenal and Humoral Function - Mayo Clinic

   To advance our understanding of the mechanisms of human cardiorenal syndrome with emphasis upon the interaction of diuretic therapy and the renal-angiotensin- ...

2. MyAirvo 3 (High Flow Nasal Therapy; HFNT) For COPD Patients In The Home - Mayo Clinic

   usual COPD medical care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients with moderate to very severe COPD at risk for ...

3. Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis - Mayo Clinic

   This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment.

4. Radiation Therapy and Docetaxel in Treating Patients with HPV-Related Oropharyngeal Cancer - Mayo Clinic

   Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor ...

5. A Study to Evaluate Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

6. Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

   About this study. This phase II trial studies how well denosumab works in treating patients with osteosarcoma that has come back (recurrent) or does not ...

7. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

   About this study. The purpose of this multicenter, double-blind, randomized, placebo-controlled study is to evaluate the safety and efficacy of emricasan in ...

8. Study to Determine the Effectiveness and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) - Mayo Clinic

   Part B: To demonstrate the efficacy of dupilumab treatment compared with placebo in adult and adolescent patients with EoE after 24 weeks of treatment as ...

9. A Study to Assess the Safety and Dose Escalation of Pegtomarginase (PT01) for Subjects with Advanced Malignancies - Mayo Clinic

   The purpose of this first-in-human (FIH) study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary activity ...

10. HL7 2.5.1 Implementation Guide

    B. HL7 ORGANIZATION MEMBERS, who register and agree to the terms of HL7's License, are authorized, without additional charge, on a perpetual (except as ...